Thyroid cancer, particularly well-differentiated thyroid cancer (WDTC), is on the rise, predominantly affecting women, with debated causes including environmental radiation exposure and genetic factors. Treatment typically involves surgery and radioiodine therapy, boasting high survival rates but posing potential long-term psychological impacts. Patients often grapple with anxiety, depression, and survivorship challenges, necessitating tailored support from healthcare providers. Unmet psychosocial needs among thyroid cancer survivors underscore the importance of long-term monitoring and awareness of psychological consequences. Cognitive impairment is a recognized consequence of thyroid cancer and its treatments, impacting attention, memory, and executive function. Social support plays a critical role in mitigating uncertainty and enhancing quality of life for survivors, while self-perceived discrimination and societal perceptions of visible scars can exacerbate distress. Adaptive coping strategies are vital in navigating the diagnosis and treatment journey. Quality of life is intricately linked to factors such as surgery extent, hypothyroidism management, and adjuvant therapies. Tools like ThyPRO offer valuable insights into patients’ daily experiences, guiding therapeutic approaches and promoting patient-centered care.